Acetylcholine-induced coronary spasm in patients with unobstructed coronary arteries is associated with elevated concentrations of soluble CD40 ligand and high-sensitivity C-reactive protein

Objectives To assess whether epicardial and microvascular coronary artery spasm in response to acetylcholine (ACH) is associated with markers of inflammation, platelet stimulation, and endothelial activation in patients with angina and unobstructed coronary arteries. Background Patients with angina pectoris despite angiographically normal coronary arteries represent a diagnostic and therapeutic challenge. Both impaired coronary microvascular dilatory responses as well as diffuse distal epicardial and microvascular coronary artery spasm have been described as possible pathogenic mechanisms. Although inflammation has been proposed to play a pathogenic role in angina, an association between ACH-induced coronary vasospasm and inflammation in Caucasians has not been reported previously in this context. Patients and methods We assessed 62 consecutive patients (26 men, age 60±10 years) with chest pain despite angiographically unobstructed coronary arteries (<50% stenosis) who underwent intracoronary ACH testing for the diagnosis of coronary artery spasm. High-sensitivity C-reactive protein (hs-CRP), e-selectin, neopterin, and sCD40L concentrations were measured in all patients before ACH testing. The ACH test was considered to be ‘positive’ in the presence of (a) angina and at least 75% coronary diameter reduction (epicardial coronary artery spasm) or (b) ischemic ST-shifts and angina in the absence of epicardial spasm (microvascular spasm). Eight patients without angina pectoris served as a control group. Results The ACH test was positive in 48 patients (77%). Twenty-seven patients had epicardial spasm (56%) and 21 patients had microvascular spasm (44%). Epicardial spasm was diffuse in 26 patients (96%) and focal in one patient (4%). Elevated hs-CRP, e-selectin, and sCD40 ligand concentrations were significantly (P⩽0.05) associated with a positive ACH-test response. Hs-CRP (odds ratio 1.54, confidence interval 1.02–2.33, P=0.04) and sCD40 ligand (odds ratio 1.001, confidence interval 1.00–1.001, P=0.003) were predictors for a positive ACH test on multivariate analysis. None of the patients in the control group developed epicardial or microvascular spasm during ACH testing. Conclusion Epicardial and microvascular coronary spasm in response to ACH correlate significantly with hs-CRP and sCD40 ligand concentrations in patients with angina pectoris and angiographically unobstructed coronary arteries. These results suggest that an association exists between inflammation and coronary artery spasm in patients with angina pectoris despite unobstructed coronary arteries and studies are needed to explore the mechanisms underlying this association.

[1]  B. Ahmed New insights into the pathophysiology, classification, and diagnosis of coronary microvascular dysfunction. , 2014, Coronary artery disease.

[2]  F. Crea,et al.  Coronary microvascular dysfunction in patients without myocardial diseases and obstructive atherosclerosis , 2014 .

[3]  J. Kaski,et al.  Clinical Usefulness, Angiographic Characteristics, and Safety Evaluation of Intracoronary Acetylcholine Provocation Testing Among 921 Consecutive White Patients With Unobstructed Coronary Arteries , 2014, Circulation.

[4]  L. Ayers,et al.  Increased myocardial prevalence of C-reactive protein in human coronary heart disease: direct effects on microvessel density and endothelial cell survival. , 2012, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[5]  J. Kaski,et al.  Obesity, Inflammation and Brachial Artery Flow-Mediated Dilatation: Therapeutic Targets in Patients with Microvascular Angina (Cardiac Syndrome X) , 2012, Cardiovascular Drugs and Therapy.

[6]  M. Kimura,et al.  In Vivo Assessment of Ergonovine-Induced Coronary Artery Spasm by 64-Slice Multislice Computed Tomography , 2012, Circulation. Cardiovascular imaging.

[7]  J. Kaski,et al.  High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. The ACOVA Study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries). , 2012, Journal of the American College of Cardiology.

[8]  F. Crea,et al.  Contemporary Reviews in Cardiovascular Medicine Mechanisms of Coronary Artery Spasm , 2011 .

[9]  J. Kaski,et al.  Elevated circulating soluble form of CD40 ligand in patients with cardiac syndrome X. , 2010, Atherosclerosis.

[10]  D. Granger,et al.  Microvascular Responses to Cardiovascular Risk Factors , 2010, Microcirculation.

[11]  T. Michel,et al.  Cellular signaling and NO production , 2010, Pflügers Archiv - European Journal of Physiology.

[12]  M. Rubens,et al.  Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease. , 2009, European heart journal.

[13]  T. Lüscher,et al.  A randomized placebo-controlled study on the effect of nifedipine on coronary endothelial function and plaque formation in patients with coronary artery disease: the ENCORE II study , 2009, European heart journal.

[14]  U. Sechtem,et al.  Coronary artery spasm as a frequent cause of acute coronary syndrome: The CASPAR (Coronary Artery Spasm in Patients With Acute Coronary Syndrome) Study. , 2008, Journal of the American College of Cardiology.

[15]  M. Sabatine,et al.  Long-Term Prognostic Value of Neopterin: A Novel Marker of Monocyte Activation in Patients With Acute Coronary Syndrome , 2007, Circulation.

[16]  R. de Caterina,et al.  Myocardial infarction with normal coronary arteries: a conundrum with multiple aetiologies and variable prognosis: an update , 2007, Journal of internal medicine.

[17]  J. Kaski,et al.  Microvascular dysfunction in cardiac syndrome X: the role of inflammation , 2006, Canadian Medical Association Journal.

[18]  N. Yang,et al.  Relation of high-sensitivity C-reactive protein level with coronary vasospastic angina pectoris in patients without hemodynamically significant coronary artery disease. , 2005, The American journal of cardiology.

[19]  H. Turhan,et al.  Increased Levels of Soluble Adhesion Molecules E-Selectin and P-Selectin in Patients with Cardiac Syndrome X , 2005, Angiology.

[20]  J. Kaski,et al.  Markers of Inflammation and Rapid Coronary Artery Disease Progression in Patients With Stable Angina Pectoris , 2004, Circulation.

[21]  A. Takeshita,et al.  Inflammatory stimuli upregulate Rho-kinase in human coronary vascular smooth muscle cells. , 2004, Journal of molecular and cellular cardiology.

[22]  K. Chayama,et al.  Relation between C reactive protein concentrations and coronary microvascular endothelial function , 2004, Heart.

[23]  J. Kaski,et al.  C-reactive protein, clinical presentation, and ischemic activity in patients with chest pain and normal coronary angiograms. , 2003, Journal of the American College of Cardiology.

[24]  Hiroaki Shimokawa,et al.  Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm. , 2003, Journal of the American College of Cardiology.

[25]  H. Fukuda,et al.  Clinical and angiographical characteristics of acetylcholine- induced spasm: relationship to dose of intracoronary injection of acetylcholine , 2002, Coronary artery disease.

[26]  A. Takeshita,et al.  Suppression of Coronary Artery Spasm by the Rho-Kinase Inhibitor Fasudil in Patients With Vasospastic Angina , 2002, Circulation.

[27]  D. Tousoulis,et al.  Vascular cell adhesion molecule‐1 and intercellular adhesion molecule‐1 serum level in patients with chest pain and normal coronary arteries (syndrome X) , 2001, Clinical cardiology.

[28]  H. Bøtker,et al.  Elevated endothelin concentrations are associated with reduced coronary vasomotor responses in patients with chest pain and normal coronary arteriograms. , 1999, Journal of the American College of Cardiology.

[29]  A. Takeshita,et al.  Angina pectoris caused by coronary microvascular spasm , 1998, The Lancet.

[30]  K. Miwa,et al.  Soluble E-selectin, ICAM-1 and VCAM-1 levels in systemic and coronary circulation in patients with variant angina. , 1997, Cardiovascular research.

[31]  R. Frye,et al.  A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. , 1975, Circulation.